US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GlobeStar Therapeutics Corporation

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:1.24K

PE:0.00

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.0003

52wk Low:0.0000

Shares:1.24B

Float Shares:1.15B

Volume Ratio:3.10

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0010

EPS(LYR):-0.0024

ROE:259.21%

ROA:-1597.98%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

GlobeStar Therapeutics Corporation

Exchange:

EXPERT

Establishment Date:

- -

Employees:

- -

Office Location:

1280 Lexington Avenue,Suite 1290,FRNT 2,New York,New York,United States

Website:

http://angiosoma.info

Zip Code:

10028

Phone:

Fax:

- -

Introduction:

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GSTC/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSTC\",,,,,undefined,":{"symbol":"GSTC","market":"US","secType":"STK","nameCN":"GlobeStar Therapeutics Corporation","latestPrice":0.000001,"timestamp":1771016400000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":1145803675,"shares":1241105695,"eps":-0.001,"marketStatus":"Market Closed","change":0,"latestTime":"02-13 16:00:00 EST Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.001,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":3.099704166714092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSTC\",,,,,undefined,":{"symbol":"GSTC","floatShares":1145803675,"roa":"-1597.98%","roe":"259.21%","lyrEps":-0.002356,"volumeRatio":3.099704166714092,"shares":1241105695,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"-0.00","week52High":0.0003,"institutionHeld":0,"latestPrice":0.000001,"eps":-0.001,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.001,"open":0.000001,"prevYearClose":0.000001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSTC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSTC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":346742204,"address":"1280 Lexington Avenue,Suite 1290,FRNT 2,New York,New York,United States","zipCode":"10028","officePhone":"509-531-1671"},"stockCompanyDetail":{"websiteUrl":"http://angiosoma.info","description":"GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.","exchange":"EXPERT","name":"GlobeStar Therapeutics Corporation","nameEN":"GlobeStar Therapeutics Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GSTC\",market:\"US\",,,undefined,":null}}